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Bone repair failure is a major complication of open
fracture, leading to non-union of broken bone
extremities and movement at the fracture site. This
results in a serious disability for patients. The role
played by the periosteum and bone marrow
progenitors in bone repair is now well documented.
In contrast, limited information is available on the role
played by myogenic progenitor cells in bone repair.
In a recent article published in BMC Musculoskeletal
Disorders, Liu et al. compared the presence of
myogenic progenitor (MyoD lineage cells) in closed
and open fractures. They showed that myogenic
progenitors are present in open, but not closed
fractures, suggesting that muscle satellite cells may
colonize the fracture site in the absence of intact
periosteum. Interestingly, these progenitors
sequentially expressed a chondrogenic and, thereafter,
an osteoblastic phenotype, suggestive of a functional
role in the repair process. This finding opens up new
perspectives for the research of orthopedic surgical
methods, which could maximize myogenic progenitor
access and mobilization to augment bone repair.
Please see related article: http://www.biomedcentral.
com/1471-2474/12/288
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Background
There are millions of fractures each year the world over,
generated by traumatic injury. According to the force of
the impact, fractures are closed with a limited angle of
dislocation, or open with a serious displacement of the
broken bone extremities inducing severe injuries of the
surrounding tissues (muscles, blood vessels, skin, nerves).
While immobilization and surgery may facilitate healing,
a fracture ultimately heals through physiological pro-
cesses in 6 to 8 weeks. Bone repair is dependent on the
presence of osteocompetent progenitors that are able to
differentiate and generate new bone. Progenitors coming
from the periosteum and the bone marrow compartment
play a pivotal role. However, there are many circum-
stances that limit the access of these primary osteopro-
genitors, for example, damage to the periosteum,
debridement to prevent infection and internal fixation.
These circumstances occur in high-energy traumatic
open fractures, which often leads to ‘non-union’ (pseu-
darthrosis or failed fracture) of the broken bone extremi-
ties. In the case of a non-union, a fracture does not heal.
The prevalence of non-union of closed tibial shaft frac-
ture is 2.5% and increases 5.7-fold for open fractures with
gross contamination and extensive soft damage [1].
Other reasons for a non-union fracture may include
complicated, multisegmental fractures (severe comminu-
tion), open fractures, fractures associated with tumors
(pathologic fractures), infection, insufficient fracture
immobilization (fixation), inadequate blood supply, poor
nutrition and chronic disease state (diabetes, renal failure,
metabolic bone disease). These fractures may lead to
severe secondary complications and disability, and result
in a high socioeconomical impact. Current treatment
requires surgery techniques, but a high percentage of fail-
ure is associated with this.
Current treatment for bone fracture
Most non-union fractures require open surgery to realign
the fracture fragments into their normal anatomical posi-
tion and stabilize the fracture by use of metal plates,
rods, screws, and/or wires. Another technique involves
the insertion of bone graft material into the surgical site,
which stimulates fracture healing. Newer approaches are
using recombinant bone morphogenic protein and bone
marrow aspirates. Bone marrow may be harvested from
the individual’s iliac crest and injected directly into the
fracture site guided by external imaging (fluoroscopy).
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Some cases, whether treated surgically or with non-inva-
sive techniques, benefit from the use of electrical, electro-
magnetic, or ultrasonic stimulation to promote fracture
healing and bone growth. Electrical stimulation may be
administered by a self-contained device surgically
implanted internally at the fracture site or by multiple
electrodes placed over the skin near the fracture site [2].
Myogenic progenitor cells in bone formation
Prevention and treatment of the non-union fracture
remains an important field of research. One area of
research is better use of local progenitors by improving
their migration to the fracture site and their differentia-
tion into bone cells. Therefore, research looking for new
progenitors is of the highest importance. In this context,
Liu et al. [3] have investigated the potential of myogenic
progenitors (MyoD-lineage cells) in bone repair in the
mouse tibia. They compared the contribution of these
cells in the repair of closed tibial fracture (where the peri-
osteum was largely intact), to the repair of open, highly
traumatic fracture featuring periosteal stripping and local
tissue trauma. Using a MyoD-Cre+:Z/AP+ conditional
reporter mouse in which all cells of MyoD lineage are
labeled with human alkaline phosphatase reporter, they
showed that myogenic progenitors are present in open,
but not closed fractures, suggesting that muscle satellite
cells may contribute to bone repair in the absence of
intact periosteum. This study documents for the first
time that muscle cells can play a significant role in bone
repair, and offers a new and valuable perspective on the
capacity of MyoD-lineage cells to contribute to bone for-
mation and fracture repair. This finding gives a rationale
to the use of muscle flaps in orthopedic surgery to treat
bone non-union, and advances current knowledge on the
beneficial effect of muscle proximity to open-fracture
healing. This paper also offers new perspectives for the
research of orthopedic surgical methods that could maxi-
mize MyoD lineage access and mobilization to augment
bone repair.
Conclusions
Liu et al. show for the first time that myogenic progenitors
of the MyoD lineage contribute to bone repair, giving new
perspectives for treatment of fracture non-union through
the optimization of myogenic progenitors proliferation,
migration and differentiation.
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